Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMLFCNY)

Drug Name

GT-389255 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Obesity	5B81	Discontinued in Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Lipase unspecific (LIP)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ApoC-III	DMBRQF5	N. A.	N. A.	Phase 3	[3]
Butylphosphonate	DMF5D1N	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011891)
2	Obesity drugs in clinical development. Curr Opin Investig Drugs. 2006 Apr;7(4):312-8.
3	An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor Int J Clin Pract. 2008 May;62(5):799-809.
4	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.